These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7932560)

  • 1. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
    Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
    J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Griswold DE; Martin LD; Tzimas MN
    J Med Chem; 1993 Sep; 36(18):2703-5. PubMed ID: 8410983
    [No Abstract]   [Full Text] [Related]  

  • 5. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
    J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
    Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
    Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
    Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
    Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisubstituted benzene leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Konno M; Nakae T; Sakuyama S; Odagaki Y; Nakai H; Hamanaka N
    Bioorg Med Chem; 1997 Aug; 5(8):1649-74. PubMed ID: 9313868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
    Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
    Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
    Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists.
    Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B
    J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
    Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
    J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.